These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 21174180)

  • 1. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
    Müller RH; Radtke M; Wissing SA
    Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S131-55. PubMed ID: 12460720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
    Shidhaye SS; Vaidya R; Sutar S; Patwardhan A; Kadam VJ
    Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery.
    Muchow M; Maincent P; Muller RH
    Drug Dev Ind Pharm; 2008 Dec; 34(12):1394-405. PubMed ID: 18665980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
    Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
    Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
    Dudhipala N; Ay AA
    Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method.
    Duong VA; Nguyen TT; Maeng HJ
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
    Thukral DK; Dumoga S; Mishra AK
    Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers.
    Darwish MKM; El-Enin ASMA; Mohammed KHA
    Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.